Total Payments
$8,055
2024 Payments
$2,142
Companies
18
Transactions
177
Medicare Patients
17,837
Medicare Billing
$1.3M
Payment Breakdown by Category
Food & Beverage$4,509 (56.0%)
Travel$3,425 (42.5%)
Education$121.44 (1.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,509 | 165 | 56.0% |
| Travel and Lodging | $3,425 | 11 | 42.5% |
| Education | $121.44 | 1 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $1,672 | 9 | $0 (2024) |
| Medtronic, Inc. | $1,516 | 14 | $0 (2024) |
| Cardiovascular Systems Inc. | $976.10 | 40 | $0 (2019) |
| Edwards Lifesciences Corporation | $903.97 | 6 | $0 (2022) |
| Baylis Medical Company Inc | $805.23 | 2 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $422.30 | 70 | $0 (2024) |
| BIOTRONIK INC. | $355.40 | 2 | $0 (2024) |
| CARDIVA MEDICAL, INC. | $317.91 | 1 | $0 (2019) |
| Abbott Laboratories | $291.01 | 5 | $0 (2024) |
| ABIOMED | $258.23 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,142 | 61 | Medtronic, Inc. ($1,291) |
| 2023 | $738.97 | 41 | Boston Scientific Corporation ($250.04) |
| 2022 | $521.19 | 11 | BIOTRONIK INC. ($220.16) |
| 2021 | $856.45 | 8 | Edwards Lifesciences Corporation ($806.47) |
| 2020 | $78.86 | 1 | Abbott Laboratories ($78.86) |
| 2019 | $2,807 | 20 | Boston Scientific Corporation ($1,318) |
| 2018 | $426.87 | 17 | Cardiovascular Systems Inc. ($399.21) |
| 2017 | $484.60 | 18 | Cardiovascular Systems Inc. ($346.83) |
All Payment Transactions
177 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: Heart Failure | ||||||
| 12/06/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $96.77 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/05/2024 | Abbott Laboratories | — | Food and Beverage | In-kind items and services | $67.41 | General |
| Category: Structural Heart | ||||||
| 12/04/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $0.67 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/03/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: Obesity | ||||||
| 11/21/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $1.66 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/08/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $1.60 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/25/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $1.82 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $23.17 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/11/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $1.70 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/09/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $11.57 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/03/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/27/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $1.53 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/25/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $131.45 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/20/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $1.17 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/13/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $1.73 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/06/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $1.79 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/06/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $0.64 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/28/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $23.49 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/28/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $0.58 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/07/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $30.01 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: DIABETES | ||||||
| 07/17/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 36 | 4,714 | 6,327 | $2.7M | $321,466 |
| 2022 | 38 | 4,615 | 6,235 | $2.7M | $335,118 |
| 2021 | 34 | 4,283 | 5,923 | $2.4M | $317,142 |
| 2020 | 33 | 4,225 | 5,975 | $2.5M | $317,667 |
Total Patients
17,837
Total Services
24,460
Medicare Billing
$1.3M
Procedure Codes
153
All Medicare Procedures & Services
153 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 509 | 723 | $400,910 | $62,246 | 15.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 196 | 387 | $270,372 | $27,388 | 10.1% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 133 | 154 | $204,810 | $26,732 | 13.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 385 | 414 | $199,086 | $21,678 | 10.9% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 37 | 47 | $158,020 | $21,508 | 13.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 182 | 182 | $134,386 | $21,479 | 16.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 113 | 283 | $93,107 | $17,642 | 18.9% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 85 | 87 | $309,324 | $15,970 | 5.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 107 | 113 | $100,392 | $15,388 | 15.3% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 24 | 24 | $76,224 | $14,832 | 19.5% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 65 | 260 | $30,940 | $11,421 | 36.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 926 | 1,102 | $185,136 | $11,034 | 6.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 998 | 1,384 | $80,272 | $8,755 | 10.9% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 74 | 148 | $19,240 | $8,455 | 43.9% |
| 33361 | Replacement of aortic valve through the skin and femoral artery | Facility | 2023 | 12 | 12 | $89,292 | $7,299 | 8.2% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 78 | 80 | $60,160 | $4,094 | 6.8% |
| Q9956 | Injection, octafluoropropane microspheres, per ml | Office | 2023 | 45 | 138 | $11,178 | $4,020 | 36.0% |
| 92978 | Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | Facility | 2023 | 43 | 47 | $63,393 | $3,553 | 5.6% |
| 93454 | Insertion of tube in coronary artery for diagnosis with review by radiologist | Facility | 2023 | 24 | 24 | $66,133 | $3,508 | 5.3% |
| 93571 | Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | Facility | 2023 | 33 | 33 | $36,705 | $1,904 | 5.2% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 33 | 34 | $20,303 | $1,878 | 9.3% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 22 | 22 | $15,664 | $1,809 | 11.5% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 67 | 67 | $9,179 | $1,320 | 14.4% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 106 | 119 | $19,955 | $1,201 | 6.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 16 | 16 | $5,248 | $1,016 | 19.4% |
About Dr. Muhammad Khan, MD
Dr. Muhammad Khan, MD is a Cardiovascular Disease healthcare provider based in Springfield, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/18/2008. The National Provider Identifier (NPI) number assigned to this provider is 1114176708.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Muhammad Khan, MD has received a total of $8,055 in payments from pharmaceutical and medical device companies, with $2,142 received in 2024. These payments were reported across 177 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($4,509).
As a Medicare-enrolled provider, Khan has provided services to 17,837 Medicare beneficiaries, totaling 24,460 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 153 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology
- Location Springfield, IL
- Active Since 09/18/2008
- Last Updated 11/29/2022
- Taxonomy Code 207RC0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1114176708
Products in Payments
- WATCHMAN (Device) $1,318
- HARMONY (Device) $1,261
- Coronary Orbital Atherectomy System (Device) $957.24
- EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) (Device) $806.47
- NRG needle (Device) $805.23
- LEQVIO (Drug) $321.10
- Vascular Closure Device (Device) $317.91
- WATCHMAN Access System (Device) $314.82
- Impella (Device) $258.23
- COREVALVE EVOLUT R (Device) $235.82
- Mitra Clip system (Device) $190.15
- Orsiro Mission (Device) $135.24
- Repatha (Biological) $128.87
- BRILINTA (Drug) $116.37
- ENTRESTO (Drug) $101.20
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (Device) $97.50
- XARELTO (Drug) $81.53
- JARDIANCE (Drug) $61.93
- ELIQUIS (Drug) $57.04
- PRALUENT ALIROCUMAB INJECTION (Biological) $27.66
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Springfield
Tony De Martini, M.d, M.D
Cardiovascular Disease — Payments: $519,196
Cardiovascular Disease $519,196
Dr. Gerard Oghlakian, Md, MD
Cardiovascular Disease — Payments: $502,096
Cardiovascular Disease $502,096
David Powell, Md, MD
Cardiovascular Disease — Payments: $196,233
Cardiovascular Disease $196,233
Robert Fishberg, Md, MD
Cardiovascular Disease — Payments: $171,370
Cardiovascular Disease $171,370
Dr. Shady Henien, M.d, M.D
Cardiovascular Disease — Payments: $104,402
Cardiovascular Disease $104,402
Dr. Shang-Chiun Lee, Md, MD
Cardiovascular Disease — Payments: $97,193
Cardiovascular Disease $97,193